TrialPath

Find a study

Browse recruiting studies near you — free to check, always your choice.

Match me to a study

387 studies

Recruiting now, in plain language. Every study is watched over by an independent ethics board.

132 studies on the map

A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants — Emory University, AtlantaEffectiveness of the Diabetes Homeless Medication Support (D-HOMES) Program on Diabetes Management — Hennepin Healthcare Research Institute, MinneapolisStatin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study — Stanford University, StanfordA Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease — Cedars Sinai Medical Center, Los AngelesCircadian Intervention to Improve Cardiometabolic Health — College of Health Research Complex--University of Utah, Salt Lake CityAcute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic Steatosis — AdventHealth Translational Research Institute, OrlandoAutologous Stem Cell Transplant for Crohn's Disease — Icahn School of Medicine at Mount Sinai, New YorkPilot of Continuous Glucose Monitor-Augmented Food Is Medicine — University of North Carolina at Chapel Hill, Chapel HillA Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease — Peak Gastroenterology Associates - Colorado Springs-Site Number: 8400039, Colorado SpringsA Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis — Del Sol Research Management, LLC - Site Number: 8400012, TucsonHealth Without Barriers/Salud Sin Barreras- Northern Colorado — Colorado State University, Fort CollinsOutcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus — Arizona Kidney Disease and Hypertension Center, PhoenixCOMPARE - Pediatric Inflammatory Bowel Disease (PIBD) — University of North Carolina at Chapel Hill, Chapel HillImpact of Morning Light Therapy in IBD — Mount Sinai Hospital, New YorkUsing Continuous Glucose Monitoring to Quantify the Effects of NOURISH's Culturally Modified Meals on Asian Americans With Type 2 Diabetes — Stanford University, StanfordClinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease — Phoenix Children's Hospital, PhoenixThe CARING Study: Creating and Restoring Health Through Nutrition Guidance — Physicians Committee for Responsible Medicine, Washington D.C.Novel Digital Patient-Reported Outcomes Tool for Diabetes Management — NYU Langone Health, New YorkLiver Transplant CGM — Mount Sinai Hospital, New YorkGLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH — Massachusetts General Hospital, BostonUnderstanding Metabolism and Inflammation Risks for Diabetes in Adolescents — University of Michigan, Ann ArborA Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome — Clinical Research Institute of Arizona, Sun City WestEffects of Ketone Ester Consumption on Exercise Tolerance and Cardiac Function — The Ross Heart Hospital, ColumbusAssessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBD — Connecticut Children's Medical Center, HartfordKetogenic Diet and Diabetes Demonstration Project — University of New Mexico, AlbuquerqueA Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC) — Digestive Health Specialsits, DothanHyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC) — University of Alabama Medicine, BirminghamTrial Against INtractable Type 2 Diabetes (CAPTAIN-T2D) — Arizona Clinical Trials - Pecos, ChandlerPregnant Women With and Without Crohns Disease to Explore the Role of Plastics and Toxins in Intestinal Inflammation — Icahn School of Medicine at Mount Sinai, New YorkA Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease — Phoenix Children's Hospital, PhoenixAssessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions — UT Southwestern Medical Center, DallasMobile App Logging for Diabetes in Pregnancy — Augusta University, AugustaDietary Insights and Nutrition Experiences in Adults on GLP-1 Therapy - A Study on Diet Quality Changes in Adults on GLP-1 Therapy — University South Carolina, ColumbiaACT Intervention for Type 2 Diabetes Management for Rural and Underserved Community — Sam Houston State University College of Osteopathic Medicine, ConroePolypill for Prevention of Cardiomyopathy — UT Southwestern Medical Center, DallasYouth-Onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort Study — Children's National Hospital (CNH), Washington D.C.A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes — Lakeview Clinical Research, GuntersvilleWild Blueberries for Gut, Brain, and Heart Health in Adults With High Blood Pressure — Georgia State University, AtlantaStudy of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis — GI Alliance, Sun CityCulturally Tailored Program for Food-Insecure Adults: SPICE-D — Wake Forest University Health Sciences, Winston-SalemA Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS) — University of Arizona, TucsonStudy of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention — Tulane University, New OrleansDiabetes Management Using Continuous Glucose Monitors and Remote Patient Monitoring in Underserved Populations — Community Health Center of Franklin County, GreenfieldAn Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitis — Erick H. Alayo Medical Corporation - Gastro SB Clinic, Chula VistaA Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD) — Woodholme Gastroenterology Associates, Glen BurnieFeasibility Test of Action Planning in Pediatric IBD — University of North Carolina-Chapel Hill School of Medicine, Chapel HillA Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D) — CenExel Anaheim Clinical Trials, AnaheimImpact of Prebiotics in Ulcerative Colitis — UCLA, Los AngelesType 2 Continuous Glucose Monitoring Academy — Children's Hospital Los Angeles, Los AngelesEffect of Statins on Crohn's Disease — Stanford University, StanfordPharmacist-led Continuous Glucose Monitoring — USF Health Department of Family Medicine, TampaSGLT2i, Ketoacidosis, Volume Contraction, and Insulinopenia — Texas Diabetes Institute/UH, San AntonioEvaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care. — WoundCentrics Wound Care & Hyperbarics -Corpus Christi - Shoreline, Corpus ChristiVirtual Diabetes Care for Adults With Type 2 Diabetes on Medicaid and Insulin Therapy — Rutgers Health Family Medicine at Monument Square, New BrunswickAcute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes — University of Texas Health Science Center at San Antonio, San AntonioPrecision Dosing of Metformin in Youth With T2D — UCSF Benioff Children's Hospital Oakland, Pediatric Diabetes Clinic, OaklandAutologous Stem Cell Transplantation for Crohn's Disease — UPMC Prebyterian- Adult Gastroenterology, PittsburghA Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers — Royal Research, HollywoodEffect of Sleep Extension on Ceramides in People with Overweight and Obesity — College of Health Research Complex--University of Utah, Salt Lake CityLY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis — Valleywise Health Medical Center, PhoenixImpact of the Enhanced Recovery After Surgery System for Colorectal Surgery — University of Arkansas for Medical Sciences, Little RockReverse-Engineering of Exclusive Enteral Nutrition (RE-EEN) in Crohn's Disease: A Multi-Center Trial — Children's Hospital of Philadelphia, PhiladelphiaAn Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab — National Institutes of Health Clinical Center, BethesdaA Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease — UCSD Medical Center, La JollaStudy of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis — Massachusetts General Hospital, BostonValue of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer. — Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, CharlestownSocial Determinants of Health, Medication Use, and Quality of Life in Inflammatory Bowel Disease — Icahn School of Medicine at Mount Sinai, New YorkSafety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes — University of Alabama, BirminghamEfficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus — Lynn Institute of the Ozarks, Little RockThe Influence of a Fasting Mimicking Diet on Ulcerative Colitis — Stanford University, Palo AltoTesting the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease — Weill Cornell Medicine, New YorkThe Role of Type 2 Diabetes on Skeletal Muscle Atrophy and Recovery Following Bed Rest in Older Adults — Translational Research Institute for Metabolism and Diabetes, OrlandoJoint Patient and Caregiver Intervention for Older African Americans With Type 2 Diabetes — Medical College of Wisconsin, MilwaukeeA Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus — Central Research Associates - Flourish - PPDS, BirminghamStudy of DISC-0974-201 in Participants With IBD and Anemia — One of a Kind Clinical Research Center, LLC, ScottsdaleMechanism of SGLT2 Inhibition in the Kidney — University of Michigan, Ann ArborPre-operative Nutrition for Elective Resection Surgery in Inflammatory Bowel Disease — NYU Langone Health, New YorkUnderstanding Ozanimod's MOA Via Mass Cytometry in Ulcerative Colitis — University of California San Diego, San DiegoSelenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies — Northwestern University, ChicagoA Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis — Investigational Site Number: 8400009, EscondidoImplementing an Effective Diabetes Intervention Among Low-Income Immigrants — NYU Langone Health, New YorkHigh Fructose Diet, the Gut Microbiome, and Metabolic Health — Mount Sinai Morningside, New YorkA Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease — Mayo Clinic in Arizona - Scottsdale, ScottsdaleHP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes — Alliance Clinical Canoga Park (Hope Clinical Research), Canoga ParkAmitriptyline for IBS-like Symptoms in Quiescent Crohn's Disease — University of Michigan, Ann ArborA Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease — Phoenix Children's Hospital /ID# 255766, PhoenixTreatment of Moderate to Severe Refractory Crohn's Disease — Mayo Clinic Arizona, ScottsdalePreventing Type 2 Diabetes in Black Emergent Adult — UNC-Chapel Hill, Chapel HillA Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis — BAMC, HoustonVirtual Reality (VR) -Directed Brain Gut Behavioral Treatment (BGBT) for Inflammatory Bowel Disease (IBD) Inpatients — University of Michigan, Ann ArborFermented Food-Supplemented Diet in Ulcerative Colitis — Stanford University, Palo AltoA Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis — Phoenix Children's Hospital /ID# 273015, PhoenixA Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002) — Clinnova Research ( Site 1042), AnaheimA Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2 Diabetes Mellitus — Clinical Trial Site, Chula VistaZymfentra (Infliximab-dyyb) REal World Cohort STudy — Yale University School of Medicine, New HavenIH, Brain Health, and T2D — University of Iowa, Iowa CityAn Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis — Onyx Clinical Research - Site Number: 8400021, PeoriaNYSCF Scientific Discovery Biobank — New York Stem Cell Foundation Research Institute, New YorkTreatment of UC With Novel Therapeutics — Brigham and Women's Hospital, Chestnut HillAchieving Routine Intervention and Screening for Emotional Health — University of Chicago, ChicagoStudy of Novel Therapeutics for Acute Remedy of Colitis — Brigham and Women's Hospital, Chestnut HillALPCO Calprotectin CLIA Assay - Measurement of Calprotectin Levels in Human Stool — Med-Care Research Corp, MiamiA Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis — Children's Healthcare of Atlanta, AtlantaStudy to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications — Evidera, a PPD Business Unit /ID# 238688, MorrisvilleA Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease — Digestive Health Specialists of the Southeast, DothanImplementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2) — University of Alabama, BirminghamAquamin® for Prevention of Ulcerative Colitis J-Pouch-associate Intestinal Inflammation — University of Michigan, Ann ArborPhase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets — Central Research Associates, LLC dba Flourish Research, BirminghamBrain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D) — Washington University School of Medicine, St LouisEfficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease — IMC Gulf Coast Gastroenterology, PC, FairhopePreventing T2DM After GDM With Immediate Postpartum Screening — University of Massachusetts Memorial Medical Center, WorcesterA Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease — United Medical Doctors, MurrietaPhase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy — Central Research Associates, LLC dba Flourish Research, BirminghamGlycemic Excursion Minimization (GEM) to Outshine Health Disparities — Georgia Prevention Institute, AugustaExercise and Intranasal Insulin in Type 2 Diabetes — Robert Wood Johnson University Hospital Clinical Research Center, New BrunswickThe Treatment of Painful Diabetic Neuropathy With Diet — AdventHealth Hendersonville, HendersonvilleEnhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients — One Robert Wood Johnson Place, New BrunswickMirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study — Digestive Health Specialists, DothanGlycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes — University Health - Texas Diabetic Institute, San AntonioMirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight — Digestive Health Specialists, DothanImplementation of Team Clinic for Type 2 Diabetes (TCT2) — Children's Hospital Los Angeles, Los AngelesComparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes — University Health System Texas Diabetic Institute, San AntonioVOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observational Study — GI Alliance - Sun City, Sun CitySubclinical Primary Aldosteronism in Diabetes At-Risk for Kidney Disease — Brigham and Women's Hospital, BostonDietary Insights and Nutritional Education in Adults on GLP-1 Therapy — University South Carolina, ColumbiaA Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease — Investigational Site Number: 8400024, TucsonBalance4Mobility: Effects of Walkasins Use in Individuals With Peripheral Neuropathy and Balance Problems — OrthoArizona--Mesa Arbor Avenue, MesaEvaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes — Sansum Diabetes Research Institute, Santa BarbaraVECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease — TLC Clinical Research Inc - Los Angeles, Los AngelesA Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis — Arkansas Children's (IP Address), Little RockStudy to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus — Lenzmeier Family Medicine, GlendaleContinuous Glucose Monitor Use in Pregnancy — University of Massachusetts Memorial Medical Center, Worcester

Showing the 150 nearest — narrow your filters for fewer, closer studies.